Aykut Karahan | Istock | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! Several drugmakers are hurrying to capitalize on one of the next major innovations coming to the booming weight loss drug market: effective, convenient and potentially affordable obesity pills. Most of the … Read more
My top 10 things to watch Thursday, July 11 The S & P 500 and Nasdaq , both on seven-session winning streaks, were looking lower after more records. The June consumer price index year over year came in around its lowest inflation level in more than three years. Stock futures were initially higher on the … Read more
Sopa Images | Lightrocket | Getty Images Pfizer on Thursday said it will move forward with a once-daily version of its weight loss pill, danuglipron, after it saw “encouraging” data in an ongoing early-stage trial. The company evaluated several once-daily formulations of the drug and identified one with “the most favorable profile.” Pfizer said it … Read more
CNBC’s Jim Cramer on Wednesday gave his take on Hims & Hers Health, a digital platform that offers telehealth services, particularly for sexual health, mental health, weight loss and skin care. Hims & Hers also provides direct-to-consumer treatments for conditions like erectile dysfunction and hair loss. Cramer suggested it might be worth starting a position … Read more
FTC Chairwoman Lina Khan testifies during the House Appropriations Subcommittee on Financial Services and General Government hearing titled “Fiscal Year 2025 Request for the Federal Trade Commission,” in Rayburn Building on Wednesday, May 15, 2024. Tom Williams | CQ-Roll Call, Inc. | Getty Images The Federal Trade Commission is planning to sue three large U.S. … Read more
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. The S & P 500 and Nasdaq climbed to new records Tuesday, extending their winning streaks to five sessions in a row. Mega-cap tech once again led the way. Goldman … Read more
CNBC’s Jim Cramer on Monday suggested that it is not just Big Tech that has the capacity to lead the market. Instead, he said, companies from other sectors need to be more innovative. “Rather than bemoaning the limited breadth of the market, maybe we should be asking why other companies aren’t joining the club,” Cramer … Read more
If you still doubt the power that the biggest stocks have over this market, Friday’s performance should dispel it: Meta Platforms added $29.95, or 5.8%, bumping its gain this year to more than 52.8%. Amazon rallied $2.41, or 1.2%, and is now up roughly 31.6% in 2024. Alphabet increased $4.78, or 2.5%, for a year-to-date … Read more
Tema ETFs has been capitalizing on the risk appetite for weight loss stocks. It is behind the GLP-1, Obesity & Cardiometabolic ETF (HRTS), which is up 26% since its inception last November. The firm’s founder and CEO Maurits Pot thinks the winning weight loss trade isn’t based on just hype. “The companies we track and … Read more
Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Aamir Ahmed Khan, PhD, Principal Electrical Engineer for Paradromics, works on the Transceiver which connects to the brain implants. Austin based Paradromics is developing a brain-computer interface to aide disabled and non-verbal patients with communication. Julia Robinson … Read more
